[1]曹技磊,王钢乐.原发性乳腺神经内分泌癌的研究进展[J].医学信息,2019,32(15):38-41.[doi:10.3969/j.issn.1006-1959.2019.15.013]
　CAO Ji-lei,WANG Gang-le.Progress Research on Primary Breast Neuroendocrine Carcinoma[J].Journal of Medical Information,2019,32(15):38-41.[doi:10.3969/j.issn.1006-1959.2019.15.013]
点击复制

原发性乳腺神经内分泌癌的研究进展()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
32卷
期数:
2019年15期
页码:
38-41
栏目:
综述
出版日期:
2019-08-01

文章信息/Info

Title:
Progress Research on Primary Breast Neuroendocrine Carcinoma
文章编号:
1006-1959（2019）15-0038-04
作者:
曹技磊; 王钢乐
首都医科大学附属北京妇产医院乳腺科，北京 100006
Author(s):
CAO Ji-lei; WANG Gang-le
Department of Breast,Beijing Maternity Hospital,Capital Medical University,Beijing 100006,China
关键词:
乳腺肿瘤; 神经内分泌肿瘤; 原发性; 非特殊型乳腺癌
Keywords:
Key words：Breast neoplasms; Neuroendocrine neoplasms; Primary; Non-specific breast cancer
分类号:
R737.9
DOI:
10.3969/j.issn.1006-1959.2019.15.013
文献标志码:
A
摘要:
原发性乳腺神经内分泌癌是乳腺癌当中的一种罕见的特殊类型，从其第一次被描述至今已有50余年历史，因业内对其认识的不断改变和加深，诊断标准也多次更新，直到2003年世界卫生组织（WHO）才首次明确了定义和诊断标准。该病发病率低，病例数少，目前对其疾病起源尚无定论，亦无针对性的临床治疗指南或规范，大样本，前瞻性的临床研究也有所缺乏，治疗往往参考非特殊型乳腺癌的方案。本文通过查阅相关文献对原发性乳腺神经内分泌癌目前的研究现状进行综述，以期对未来临床研究方向提供建议和参考，为今后的临床实践提供更多借鉴和帮助。
Abstract:
Abstract：Primary breast neuroendocrine carcinoma is a rare and special type of breast cancer. It has been described for more than 50 years since its first description. Due to the constant changes and deepening of its understanding in the industry, the diagnostic criteria have been updated many times. It was not until 2003 that the World Health Organization (WHO) first defined definitions and diagnostic criteria. The incidence of the disease is low, the number of cases is small, the origin of the disease is still inconclusive, there is no targeted clinical treatment guidelines or norms, large samples, prospective clinical research is also lacking, treatment often refers to non-specific breast cancer program. This article reviews the current research status of primary breast neuroendocrine carcinoma by consulting relevant literature, in order to provide suggestions and references for future clinical research directions, and provide more reference and help for future clinical practice.

参考文献/References:

[1]Feyrter F,Hartmann G.On the carcinoid growth form of the carcinoma mammae,especially the carcinoma solidum（gelatinosum）mammae[J].Frankf Z Pathol,1963(73):24-39. [2]Cubilla AL,Woodruff JM.Primary carcinoid tumor of the breast.A report of 8 patients[J].Am J Surg Pathol,1977,1(4):283-292. [3]Sapino A,Righi L,Cassoni P,et al.Expression of the neuroendocrine phenotype in carcinomas of the breast[J].Semin Diagn Pathol,2000,17(2):127-137. [4]Tan PH,Schnin SJ,van de Vijver MJ,et al.Papillary and neuroendocrinebreast lesions:the WHO[J].Histopathology,2015,66(6):761-770. [5]Bussolati G,Gugliotta P,Sapino A,et al.Chromogranin-reactive endocrine cells in argyrophilic carcinomas("carcinoids")and normal tissue of the breast[J].Am J Pathol,1985,120(2):186-192． [6]Miura K,Nasu H,Ogura H.Double neuroendocrine ductal carcinomas in situ coexisting with a background of diffuse idiopathic neuroendocrine cell hyperplasia of breast:A case report and hypothesis of neuroendocrine tumor development[J].Pathol Int,2012,62(5):331-334. [7]Maluf HM,Koerner FC.Carcinomas of the breast with endocrine differentiation:a review[J]. Virchows Arch,1994,425(5):449-457. [8]皋岚湘,丁华野,李琳,等.乳腺神经内分泌癌的临床病理学特点[J].临床与实验病理学杂志,2003,19(3):236-241. [9]Inno A,Bogina G,Turazza M,et al.Neuroendocrine carcinoma of the breast:current evidence and future perspectives[J].Oncologist,2016,21(1):28-32. [10]Wei B,Ding T,Xing Y,et al.Invasive neuroendocrine carcinoma of the breast:a distinctive subtype of aggressive mammary carcinoma[J].Cancer.2010,116(19):4463-4473. [11]Zekioglu O,Erhan Y,Ciris M,et al.Neuroendocrine differentiated carcinomas of the breast: a distinct entity[J].Breast,2003,12(4):251-257. [12]Bogina G,Munari E,Brunelli M,et al.Neuroendocrine differentiation in breast carcinoma: clinicopathological features and outcome[J].Histopathology,2016,68(3):422-432. [13]Mohanty SK,Kim SA,DeLair DF,et al.Comparison of metastatic neuroendocrine neoplasms to the breast and primary invasive mammary carcinomas with neuroendocrine differentiation[J].Mod Pathol, 2016,29(8):788-798. [14]Gustafsson BI,Kidd M,Modlin IM.Neuroendoerine tumors of the diffuse neumendocrine system[J].Curt Opin Oncol,2008,20(1):1-12. [15]Perry KD,Reynolds C,Rosen DG,et al.Metastatic neuroendocrine tumour in the breast:a potential mimic of in-situ and invasive mammary carcinoma[J].Histopathology,2011,59(4):619-630. [16]Yildirim Y,Elagoz S,Koyuncu A,et al.Managementof neuroendocrine carcinomas of the breast:A rare entity[J].Oncol Lett,2011,2(5):887-890. [17]Ogawa H,Nishio A,Satake H,et al.Neuroendocrine tumor in the breast[J].Radiat Med,2008(26):28-32. [18]López-Bonet E,Alonso-Ruano M,Barraza G,et al.Solid neuroendocrine breast carcinomas: incidence,clinico-pathological features and immunohistochemical profiling[J].Oncol Rep,2008,20(6):1369-1374. [19]Park WM,Wu Y,Wei W,et al.Primary neuroendocrine carcinoma of the breast:clinical,imaging and histologic features[J].AJR Am J Roentgenol,2014,203(2):W221-W230. [20]毛勤香,廖昕,徐维敏,等.乳腺神经内分泌癌的临床、影像学表现及病理分析[J].临床放射学杂志,2017,36(2):199-203. [21]Upalakalin JN,Collins LC,Tawa N,et al.Carcinoid tumors in the breast[J].Am J Surg,2006,191(6):799 -805. [22]Zhang Y,Chen Z,Bao Y,et al.Invasive neuroendocrine carcinoma of the breast:a prognostic research of 107 Chinese patients[J].Neoplasma,2013,60(2):215-222. [23]Cloyd JM,Yang RL,Allison KH,et al.Impact of histological subtype on long-term outcomes of neuroendocrine carcinoma of the breast[J].Breast Cancer Res Treat,2014,148(1):637-664. [24]程玉书,周正荣,杨文涛,等.乳腺神经内分泌癌的影像学表现和临床病理特征[J].中华肿瘤杂志,2012,34(12):917-922. [25]张韵华,刘利民,夏罕生,等.乳腺神经内分泌癌的超声影像学表现[J].中国临床医学,2012,22(6):784-786. [26]黄丹凤,唐丽娜,沈友洪,等.乳腺神经内分泌癌的超声表现与鉴别诊断[J].福建医药杂志,2019,41(1):69-71. [27]Yoon YS,Kim SY,Lee JH,et al.Primary neuroendocrine carcinoma of the breast:Radiologic and pathologic correlation[J].Clin Imaging,2014,38(5):734-738. [28]龙再颖,赵燕霞,孙达.乳腺神经内分泌癌99Tcm-MIBI显像表现一例[J].国际放射医学核医学杂志,2016,40(4):318-320. [29]Righi L,Sapino A,Marchiò C,et al.Neuroendocrine differentiation in breast cancer: established facts and unresolved problems[J].Semin Diagn Pathol,2010,27(1):69-76. [30]Suhani,Ali S,Desai G,et al.Primary neuroendocrine carcinoma breast:our experience[J]. Breast Dis,2014,34(3):95-99. [31]Yao JC,Hassan M,Phan A,et al.One hundred years after "carcinoid":epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States[J].J Clin Oncol,2002,6(18):3063-3072. [32]Berruti A,Saini A,Leonardo E,et al.Management of neuroendocrine differentiated breast carcinoma[J].Breast,2004,13(6):527-529. [33]Latif N,Rosa M,Samian L,et al.An unusual case of primary small cell neuroendocrine carcinoma of the breast[J].Breast J,2010,16(6):647-651. [34]Brask J B,Talman M L M,Wielenga V T.Neuroendocrine carcinoma of the breast - a pilot study of a Danish population of 240 breast cancer patients[J].APMIS,2014,122(7):585-592. [35]Makretsov N,Gilks CB,Coldman AJ,et al.Tissue microarray analysis of neuroendocrine differentiation and its prognostic significance in breast cancer[J].Hum Patho,2003,34(10): 1001-1008. [36]Miremadi A,Pinder SE,Lee AH,et al.Neuroendocrine differentiation and prognosis in breast adenocarcinoma[J].Histopathology,2002,40(3):215-222. [37]van Krimpen C,Elferink A,Broodman CA,et al.The prognostic influence of neuroendocrine differentiationin breast cancer:results of a long-term follow-up study[J].Breast,2004.13(4): 329-333.

相似文献/References:

[1]张世玉,刘汉成,张宏旭,等.早期乳腺癌患者血清中VEGF-C与前哨淋巴结状态的相关性研究[J].医学信息,2018,31(02):71.[doi:10.3969/j.issn.1006-1959.2018.02.024]
　ZHANG Shi-yu,LIU Han-cheng,ZHANG Hong-xu,et al.Correlation between Serum VEGF-C and Sentinel Lymph Node Status in Patients with Early Stage Breast Cancer[J].Journal of Medical Information,2018,31(15):71.[doi:10.3969/j.issn.1006-1959.2018.02.024]
[2]李 科.骨形态发生蛋白4与乳腺癌骨转移的相关性研究[J].医学信息,2018,31(13):17.[doi:10.3969/j.issn.1006-1959.2018.13.005]
　LI Ke.Relationship between Bone Morphogenetic Protein 4 and Bone Metastasis in Breast Cancer[J].Journal of Medical Information,2018,31(15):17.[doi:10.3969/j.issn.1006-1959.2018.13.005]
[3]黄 雨,楼浩男,涂 刚.Luminal B型乳腺癌TEC新辅助化疗疗效及影响因素分析[J].医学信息,2019,32(04):104.[doi:10.3969/j.issn.1006-1959.2019.04.033]
　HUANG Yu,LOU Hao-nan,TU Gang.Analysis of the Efficacy and Influencing Factors of Neoadjuvant Chemotherapy for Luminal B Breast Cancer[J].Journal of Medical Information,2019,32(15):104.[doi:10.3969/j.issn.1006-1959.2019.04.033]
[4]黄冬玲,刘奕仕,黄雪韵,等.高频超声结合BI-RADS分级在乳腺良恶性病变中的应用价值[J].医学信息,2019,32(10):67.[doi:10.3969/j.issn.1006-1959.2019.10.023]
　HUANG Dong-ling,LIU Yi-shi,HUANG Xue-yun,et al.Application Value of High Frequency Ultrasound Combined with BI-RADS Classification in Benign and Malignant Breast Lesions[J].Journal of Medical Information,2019,32(15):67.[doi:10.3969/j.issn.1006-1959.2019.10.023]
[5]林 艳,林 倩,刘婷莉,等.重组IL-12对人乳腺癌细胞自噬的研究[J].医学信息,2019,32(23):64.[doi:10.3969/j.issn.1006-1959.2019.23.018]
　LIN Yan,LIN Qian,LIU Ting-li,et al.Study on Autophagy of Human Breast Cancer Cells by Recombinant IL-12[J].Journal of Medical Information,2019,32(15):64.[doi:10.3969/j.issn.1006-1959.2019.23.018]
[6]黄瑞岁,赵沁萍,丁 可,等.多模态MRI对乳腺X线摄影非肿块病变的诊断价值[J].医学信息,2020,33(08):84.[doi:10.3969/j.issn.1006-1959.2020.08.027]
　HUANG Rui-sui,ZHAO Qin-ping,DING Ke,et al.Diagnostic Value of Multi-modality MRI in Non-mass Lesions of Mammography[J].Journal of Medical Information,2020,33(15):84.[doi:10.3969/j.issn.1006-1959.2020.08.027]
[7]董智芬,郭建锋.边缘不光整乳腺癌的超声图像分析[J].医学信息,2020,33(09):152.[doi:10.3969/j.issn.1006-1959.2020.09.051]
　DONG Zhi-fen,GUO Jian-feng.Ultrasound Image Aanalysis of Breast Cancer with Irregular Edge[J].Journal of Medical Information,2020,33(15):152.[doi:10.3969/j.issn.1006-1959.2020.09.051]
[8]王 东.超声弹性成像在乳腺肿瘤良恶性诊断中的临床价值[J].医学信息,2020,33(16):178.[doi:10.3969/j.issn.1006-1959.2020.16.059]
　WANG Dong.The Clinical Value of Ultrasound Elastography in the Diagnosis of Benign and Malignant Breast Tumors[J].Journal of Medical Information,2020,33(15):178.[doi:10.3969/j.issn.1006-1959.2020.16.059]
[9]徐茂林,高 斌.DWI和DCE-MRI鉴别诊断乳腺良恶性病变的价值[J].医学信息,2021,34(05):96.[doi:10.3969/j.issn.1006-1959.2021.05.027]
　XU Mao-lin,GAO Bin.The Value of DWI and DCE-MRI in Differential Diagnosis of Benign and Malignant Breast Lesions[J].Journal of Medical Information,2021,34(15):96.[doi:10.3969/j.issn.1006-1959.2021.05.027]

更新日期/Last Update: 2019-08-01